Ardent Health, Inc. (ARDT) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
Ardent Health, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $34,689,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $111,139,000.00Accrued salaries and benefits → Operating adjustments reconciliation: $48,650,000.00Depreciation and amortization → Operating adjustments reconciliation: $41,342,000.00Equity-based compensation → Operating adjustments reconciliation: $7,952,000.00Inventories → Operating adjustments reconciliation: $3,816,000.00Deferred income taxes → Operating adjustments reconciliation: $3,497,000.00Income from non-consolidated affiliates → Operating adjustments reconciliation: $910,000.00Amortization of deferred financing costs and debt discounts → Operating adjustments reconciliation: $811,000.00Operating adjustments reconciliation → Net cash from operating activities: $162,046,000.00Operating adjustments reconciliation → Accounts payable and other accrued expenses and liabilities: $46,201,000.00Operating adjustments reconciliation → Accounts receivable: $9,870,000.00Net cash used in investing activities → investing reconciliation: $39,181,000.00investing reconciliation → Purchases of property and equipment: $38,678,000.00investing reconciliation → Other: $503,000.00Net cash used in financing activities → financing reconciliation: $42,770,000.00Other → financing reconciliation: $1,728,000.00financing reconciliation → Distributions to noncontrolling interests: $22,829,000.00financing reconciliation → Repurchase of common stock: $13,031,000.00financing reconciliation → Payments of principal on insurance financing arrangements: $5,344,000.00financing reconciliation → Payments of principal on long-term debt: $3,294,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $609,692,000.00Net cash from operating activities → Cash sources and uses: $196,735,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $724,476,000.00Cash sources and uses → Net cash used in investing activities: $39,181,000.00Cash sources and uses → Net cash used in financing activities: $42,770,000.00Deferred income taxes: $3,497,000.00Deferred income taxes+$3.50 MIncome from non-consolidated affiliates: $910,000.00Subsidiary stock sale gain/loss+$910.00 KOther non-operating (gains) losses: $0.00Depreciation and amortization: $41,342,000.00Depreciation & amortization+$41.34 MPrepaid expenses and other current assets: $111,139,000.00Prepaid & other assets+$111.14 MInventories: $3,816,000.00Inventories+$3.82 MNet income: $34,689,000.00Net income+$34.69 MAccounts receivable: -$9,870,000.00Accounts receivable−$9.87 MEquity-based compensation: $7,952,000.00Stock-based compensation+$7.95 MAmortization of deferred financing costs and debt discounts: $811,000.00Debt cost amortization+$811.00 KAccrued salaries and benefits: $48,650,000.00Accrued salaries & wages+$48.65 MAccounts payable and other accrued expenses and liabilities: -$46,201,000.00Other payables & accruals−$46.20 MNet cash from operating activities: $196,735,000.00Operating cash+$196.74 MOperating adjustments reconciliation: $218,117,000.00Proceeds from insurance financing arrangements: $0.00Payments of principal on insurance financing arrangements: -$5,344,000.00Insurance financing repaid−$5.34 MPayments of principal on long-term debt: -$3,294,000.00Long-term debt repaid−$3.29 MDistributions to noncontrolling interests: -$22,829,000.00Paid to noncontrolling interests−$22.83 MOther: $1,728,000.00Other financing, net+$1.73 MRepurchase of common stock: -$13,031,000.00Common stock repurchases−$13.03 MNet cash used in financing activities: -$42,770,000.00. Cash required to fund net payments.Financing cash−$42.77 Mfinancing reconciliation: $44,498,000.00Purchases of property and equipment: -$38,678,000.00Capital spending, net−$38.68 MOther: -$503,000.00Other investing, net−$503.00 KNet cash used in investing activities: -$39,181,000.00. Cash required to fund net payments.Investing cash−$39.18 Minvesting reconciliation: $39,181,000.00Cash sources and uses: $806,427,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $609,692,000.00Beginning cash$609.69 MEnding cash: Cash, cash equivalents, and restricted cash: $724,476,000.00Ending cash$724.48 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flowNot availableCash flow / Net income5.67×Operating cash flow ÷ net incomeNet cash change+$114.78 MEnding cash − beginning cash
Chart details

Ardent Health, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
609,692,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
196,735,000 US dollars. Net cash provided.
Deferred income taxes
3,497,000 US dollars
Income from non-consolidated affiliates
910,000 US dollars
Other non-operating (gains) losses
0 US dollars
Depreciation and amortization
41,342,000 US dollars
Prepaid expenses and other current assets
111,139,000 US dollars
Inventories
3,816,000 US dollars
Net income
34,689,000 US dollars
Accounts receivable
negative 9,870,000 US dollars
Equity-based compensation
7,952,000 US dollars
Amortization of deferred financing costs and debt discounts
811,000 US dollars
Accrued salaries and benefits
48,650,000 US dollars
Accounts payable and other accrued expenses and liabilities
negative 46,201,000 US dollars
Investing activities
negative 39,181,000 US dollars. Net cash used.
Purchases of property and equipment
negative 38,678,000 US dollars
Other
negative 503,000 US dollars
Financing activities
negative 42,770,000 US dollars. Net cash used.
Proceeds from insurance financing arrangements
0 US dollars
Payments of principal on insurance financing arrangements
negative 5,344,000 US dollars
Payments of principal on long-term debt
negative 3,294,000 US dollars
Distributions to noncontrolling interests
negative 22,829,000 US dollars
Other
1,728,000 US dollars
Repurchase of common stock
negative 13,031,000 US dollars
Operating adjustment reconciliation
218,117,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
44,498,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
39,181,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
724,476,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
806,427,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
114,784,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
5.67×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $162.05M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
Ardent Health, Inc. (ARDT) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!